文献速递生殖医学母胎医学

单基因病植入前遗传学检测的使用及后续产前保健与诊断检测

Use of preimplantation genetic testing for monogenic disorders and subsequent prenatal care and diagnostic testing.
PubMed 文献 · Prenat Diagn · 2022-06-06

该回顾性研究分析了2012至2019年间单基因病植入前遗传学检测(PGT-M)后妊娠阳性的患者,共142例完成IVF周期并妊娠超过10周,其中2012至2015年46周期,2016至2019年96周期。在130例有随访资料的患者中,16例(12%)接受了产前诊断检测,114例未接受。作者认为随着PGT-M应用增加,遗传咨询师和妇产科医生需了解该人群特征及如何咨询残留风险。

要点

  • 2012至2019年间共142例患者完成PGT-M的IVF周期并妊娠超过10周。
  • PGT-M周期数随时间增加:2012至2015年46周期,2016至2019年96周期。
  • 有随访的130例中,16例(12%)接受产前诊断检测,114例未接受。

核心结论

  • 随着PGT-M在孕前应用增加,遗传咨询师和妇产科医生需了解接受PGT-M患者的特征和结局,包括如何咨询PGT-M后妊娠受累的残留风险。

研究设计与样本

  • 回顾性研究,查询内部辅助生殖技术数据库并结合病历回顾,纳入2012至2019年PGT-M后妊娠试验阳性的患者。
  • 共142例患者完成PGT-M的IVF周期并妊娠超过10周。

主要发现

  • PGT-M周期数随时间增加:2012至2015年46周期,2016至2019年96周期。
  • 在有已知随访的130/142例患者中,16例(12%)接受了产前诊断检测,114例未接受。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The goal of preimplantation genetic testing for monogenic or single gene defects (PGT-M) is to identify inherited pathogenic variants in the embryo prior to embryo transfer, increasing the likelihood of an unaffected child. Prenatal diagnostic testing is recommended to confirm the results of PGT-M. The purpose of this study was to characterize the population undergoing PGT-M over time. METHODS: This retrospective study examined patients who had a positive pregnancy test after PGT-M from 2012 to 2019. A query of the internal assisted reproductive technology database and chart review were used. RESULTS: One hundred and 42 patients completed IVF cycles for PGT-M during this time period and progressed past 10 weeks gestation. There were more PGT-M cycles over time with 46 cycles between 2012 and 2015 and 96 cycles between 2016 and 2019. Patients varied on the decision to pursue prenatal diagnostic testing after PGT-M. For those with known follow-up (130/142), 16 patients underwent diagnostic testing (12%) and 114 did not. CONCLUSION: As PGT-M is increasingly utilized prior to pregnancy, it is important for genetic counselors and OB/GYNs to understand the characteristics and outcomes of the population of patients undergoing PGT-M, including how to counsel about the residual risk of an affected pregnancy after PGT-M.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Bunnell ME, Dobson LJ, Lanes A, et al. Use of preimplantation genetic testing for monogenic disorders and subsequent prenatal care and diagnostic testing. Prenat Diagn. 2022. PMID: 35621158. doi:10.1002/pd.6189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。